A rollover study to learn about the effects of palovarotene in people older than 14 years of age with fibrodysplasia ossificans progressiva (FOP) who have completed certain previous studies of palovarotene.
A rollover study to learn about the effects of palovarotene in people older than 14 years of age with fibrodysplasia ossificans progressiva (FOP) who have completed certain previous studies of palovarotene.
Palovarotene
A rollover study to learn about the effects of palovarotene in people older than 14 years of age with fibrodysplasia ossificans progressiva (FOP) who have completed certain previous studies of palovarotene.
